AU649802B2 - Stabilized vitamin D preparation - Google Patents

Stabilized vitamin D preparation

Info

Publication number
AU649802B2
AU649802B2 AU14804/92A AU1480492A AU649802B2 AU 649802 B2 AU649802 B2 AU 649802B2 AU 14804/92 A AU14804/92 A AU 14804/92A AU 1480492 A AU1480492 A AU 1480492A AU 649802 B2 AU649802 B2 AU 649802B2
Authority
AU
Australia
Prior art keywords
active compound
pharmaceutical composition
heat
vitamin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU14804/92A
Other languages
English (en)
Other versions
AU1480492A (en
Inventor
Hiroki Itoh
Junichi Kikuta
Tetsuro Tabata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU1480492A publication Critical patent/AU1480492A/en
Application granted granted Critical
Publication of AU649802B2 publication Critical patent/AU649802B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU14804/92A 1991-04-09 1992-04-09 Stabilized vitamin D preparation Ceased AU649802B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3-76210 1991-04-09
JP7621091 1991-04-09
JP4-19099 1992-02-04
JP1909992 1992-02-04

Publications (2)

Publication Number Publication Date
AU1480492A AU1480492A (en) 1992-10-15
AU649802B2 true AU649802B2 (en) 1994-06-02

Family

ID=26355908

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14804/92A Ceased AU649802B2 (en) 1991-04-09 1992-04-09 Stabilized vitamin D preparation

Country Status (14)

Country Link
US (1) US5487900A (OSRAM)
EP (1) EP0508756B1 (OSRAM)
JP (1) JPH05279260A (OSRAM)
KR (1) KR100231633B1 (OSRAM)
AT (1) ATE144424T1 (OSRAM)
AU (1) AU649802B2 (OSRAM)
CA (1) CA2065603C (OSRAM)
DE (1) DE69214704T2 (OSRAM)
DK (1) DK0508756T3 (OSRAM)
ES (1) ES2094290T3 (OSRAM)
GR (1) GR3021892T3 (OSRAM)
IE (1) IE75709B1 (OSRAM)
NZ (1) NZ242271A (OSRAM)
TW (1) TW212761B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701264A1 (de) * 1997-01-16 1998-07-23 Kief Lizenz Verwertungsgesells Heilmittel, enthaltend Betasitosterin und/oder Phytosterol/Betasitosteringemische
AU2001278956B2 (en) * 2000-07-18 2007-04-05 Genzyme Corporation Stabilized 1alpha-hydroxy vitamin d
CA2425367A1 (en) * 2000-08-30 2003-04-07 Chugai Seiyaku Kabushiki Kaisha Oct formulations
JP2005515996A (ja) * 2001-12-03 2005-06-02 ノバセア インコーポレイティッド 活性型ビタミンｄ化合物を含む薬学的組成物
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
CA2924200C (en) * 2005-10-12 2017-09-05 Proventiv Therapeutics, Llc Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
WO2007092755A2 (en) 2006-02-03 2007-08-16 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
US8329677B2 (en) 2006-06-21 2012-12-11 Cytochroma, Inc. Method of treating and preventing secondary hyperparathyroidism
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
EP3335712B1 (en) 2007-04-25 2025-09-10 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
EP2148661B1 (en) 2007-04-25 2012-12-12 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
CA2797537C (en) 2010-03-29 2021-11-23 Cytochroma Inc. Use of 25-hydroxyvitamin d compound for reducing parathyroid levels
CA2698160C (en) * 2010-03-30 2017-07-25 Alphora Research Inc. Stabilized doxercalciferol and process for manufacturing the same
EP2468265A3 (en) * 2010-12-04 2013-01-02 DEEF Pharmaceutical Industries Co. Homogeneous preparations containing vitamin D
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法
JP7085105B2 (ja) * 2016-11-10 2022-06-16 日産化学株式会社 ビタミンｄ３誘導体の製剤
PE20211489A1 (es) 2018-08-31 2021-08-11 Opko Ireland Global Holdings Ltd Formas de dosificacion pediatricas de vitamina d, metodos de elaboracion y uso

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801460A (en) * 1986-04-11 1989-01-31 Basf Aktiengesellschaft Preparation of solid pharmaceutical forms
US5158944A (en) * 1989-03-01 1992-10-27 Teijin Limited Solid pharmaceutical preparations of active form of vitamin d3 of improved stability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
JPS6217A (ja) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd 安定な活性型ビタミンｄ３類製剤
JPH04198129A (ja) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd 活性型ビタミンｄ↓３類含有組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801460A (en) * 1986-04-11 1989-01-31 Basf Aktiengesellschaft Preparation of solid pharmaceutical forms
US5158944A (en) * 1989-03-01 1992-10-27 Teijin Limited Solid pharmaceutical preparations of active form of vitamin d3 of improved stability

Also Published As

Publication number Publication date
US5487900A (en) 1996-01-30
GR3021892T3 (en) 1997-03-31
KR920019346A (ko) 1992-11-19
ATE144424T1 (de) 1996-11-15
EP0508756B1 (en) 1996-10-23
CA2065603A1 (en) 1992-10-10
IE921126A1 (en) 1992-10-21
JPH05279260A (ja) 1993-10-26
EP0508756A1 (en) 1992-10-14
DE69214704T2 (de) 1997-04-17
KR100231633B1 (ko) 1999-11-15
DE69214704D1 (de) 1996-11-28
ES2094290T3 (es) 1997-01-16
DK0508756T3 (da) 1997-03-24
CA2065603C (en) 2007-04-03
NZ242271A (en) 1993-10-26
AU1480492A (en) 1992-10-15
TW212761B (OSRAM) 1993-09-11
IE75709B1 (en) 1997-09-10

Similar Documents

Publication Publication Date Title
AU649802B2 (en) Stabilized vitamin D preparation
CA2027592A1 (en) Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
EP0519428A3 (en) Cyclodextrin composition
US4764604B1 (OSRAM)
AU3317589A (en) Antacid compositions with prolonged gastric residence time
AU1033292A (en) Indole piperazine derivatives and pharmaceutical preparations containing such derivatives
AU3426795A (en) Solid pharmaceutical composition comprising an excipient capable of binding water
AU653034B2 (en) Cosmetic composition
DK0588539T3 (da) Stabiliserede farmaceutiske præparater indeholdende derivater af vitamin D2 og D3
AU2125192A (en) New naphthylethlylureas and naphthylethylthioureas, process for the preparation thereof, and pharmaceutical compositions containing them
CA2083333A1 (en) High dosage topical forms of collagenase
AU5195593A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
IL105646A0 (en) Sulfonylbenzyl-substituted benzo-and pyridopyridones,their preparation and pharmaceutical compositions containing them
AU7043187A (en) Dispersible composition of ceramic solid and a dispersant
CA2063689A1 (en) Ibuprofen lysinate pharmaceutical formulation
EP0533516A3 (fr) Nouveaux composés amidiques des 1-(alcoxybenzyl) pipérazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent
GB9112495D0 (en) Improved formulations of acetazolamide
AU3138389A (en) Peptides with pharmaceutical activity
IL102880A0 (en) Hexahydrobenzo(f)quinolinones
AU570596B2 (en) Stabilized amitraz pesticides solutions
AU1509388A (en) Substituted quinoxalyl-imidazolidine-2,4-diones, processes for their preparation, their use as medicaments and pharmaceutical preparations
AU5140490A (en) Use of mixed micelles
DK0384416T3 (da) Farmaceutisk sammensætning indeholdende hydantoinderivat